-transparent.png){kind=logo}
Rats received intraventricular (i.v.t.) injections of 5,7-dihydroxytryptamine (5,7-DHT) (100-600 micrograms). Some animals also received intraperitoneal injections of the 5-hydroxytryptamine uptake blocker fluoxetine (FX) (20 mg/kg) or the norepinephrine uptake blocker desmethylimipramine (DMI) (48 mg/kg) 30-90 min prior to i.v.t. 5,7-DHT. Rats were killed between 2 and 35 days following i.v.t. 5,7-DHT, brains were dissected, and regions were assayed for thyrotropin-releasing hormone (TRH) by radioimmunoassay. Dose-dependent increases in TRH content following i.v.t. 5,7-DHT were noted in the brainstem and hippocampus. DMI pretreatment blocked the increase in hippocampal TRH, but not in brainstem TRH. FX pretreatment was ineffective in blocking any increases in TRH content. These results suggest differential regulation of regional TRH content by interactions with specific neurotransmitter systems.
S Manaker, and
T M Engber, and
P B Knight, and
A Winokur
January 1986,
Brain research,
S Manaker, and
T M Engber, and
P B Knight, and
A Winokur
February 1985,
Brain research,
S Manaker, and
T M Engber, and
P B Knight, and
A Winokur
January 1984,
Neuropharmacology,
S Manaker, and
T M Engber, and
P B Knight, and
A Winokur
July 1973,
Journal of neurochemistry,
S Manaker, and
T M Engber, and
P B Knight, and
A Winokur
October 2001,
Neurochemical research,
S Manaker, and
T M Engber, and
P B Knight, and
A Winokur
August 1988,
Pharmacology, biochemistry, and behavior,
S Manaker, and
T M Engber, and
P B Knight, and
A Winokur
September 1976,
Brain research,
S Manaker, and
T M Engber, and
P B Knight, and
A Winokur
December 2006,
The Journal of physiology,
S Manaker, and
T M Engber, and
P B Knight, and
A Winokur
August 1994,
Brain research,
S Manaker, and
T M Engber, and
P B Knight, and
A Winokur
July 1974,
Science (New York, N.Y.),
